S&P Global Inc. (SPGI)
Buenos Aires Exchange · Argentina · prices in ARS · close of 22 Oct 2026
Key indicators
| Last close | ARS 16,450.00 |
|---|---|
| 52-week range | 11,780.00 – 19,200.00 |
| Return, 1 month / 3 months | +15.2% / +9.5% |
| Return, 1 year / 3 years | −3.3% / +111.6% |
| Trend | Uptrend |
| RSI (14) | 79 |
| Volatility (1 year) | 33.0% |
| Worst drawdown (1 year) | -32.3% |
| Average daily value traded | 80.64M ARS |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
S&P Global Inc. is a provider of credit ratings, benchmarks and analytics for the financial markets. Through its ratings business it assesses the creditworthiness of issuers and debt instruments, while its indices unit maintains widely followed stock market benchmarks. Its market intelligence and commodity insights divisions supply data, research and price assessments to investors, corporations and governments. The company is based in the United States and serves clients around the world.
S&P Global Inc. trades under the code SPGI on the Buenos Aires Exchange in Argentina. Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
S&P Global Inc. (SPGI) trades on the Buenos Aires Exchange in Argentina. It last closed at ARS 16,450.00 on 22 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 76 of 154 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 3.3% and over the last three months it rose 9.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Buenos Aires Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 11.8% | ||
| From 52-week high | -14.3% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 9.5% | ||
| 6-month return | 12.6% | ||
| 12-month return, skipping the last month | -16.1% | ||
| Stability (higher is calmer) | 59 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.3% | ||
| Liquidity | 44 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 80.64M ARS | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +7.9% |
|---|---|
| 1 month | +15.2% |
| 3 months | +9.5% |
| 6 months | +12.6% |
| 1 year | −3.3% |
| 3 years | +111.6% |
| 5 years | – |
Signals
| 50-day / 200-day average | 14,901.27 / 14,713.99 |
|---|---|
| Golden / death cross (60 days) | Golden, 4 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 414.34 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Aug 2026 | USD 32.5668 |
| 29 May 2026 | USD 30.4134 |
| 25 Feb 2026 | USD 29.6675 |
| 25 Nov 2025 | USD 30.3867 |
| 26 Aug 2025 | USD 28.9105 |
| 28 May 2025 | USD 36,330.4400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Buenos Aires Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.